BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16275227)

  • 1. Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact.
    Lukes AS; Kadir RA; Peyvandi F; Kouides PA
    Fertil Steril; 2005 Nov; 84(5):1338-44. PubMed ID: 16275227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding.
    Kouides PA; Conard J; Peyvandi F; Lukes A; Kadir R
    Fertil Steril; 2005 Nov; 84(5):1345-51. PubMed ID: 16275228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Appropriate laboratory investigation in women with menorrhagia].
    de Raucourt E; Ternisien C
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S317-28. PubMed ID: 19268209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process.
    Munro MG; Lukes AS;
    Fertil Steril; 2005 Nov; 84(5):1335-7. PubMed ID: 16275226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of excessive menstrual bleeding in women with hemostatic disorders.
    Kadir RA; Lukes AS; Kouides PA; Fernandez H; Goudemand J
    Fertil Steril; 2005 Nov; 84(5):1352-9. PubMed ID: 16275229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menorrhagia and bleeding disorders.
    El-Hemaidi I; Gharaibeh A; Shehata H
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):513-20. PubMed ID: 18007127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The condensed MCMDM-1 VWD bleeding questionnaire as a predictor of bleeding disorders in women with unexplained menorrhagia.
    Azzam HA; Goneim HR; El-Saddik AM; Azmy E; Hassan M; El-Sharawy S
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):311-5. PubMed ID: 22450545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel.
    James AH; Kouides PA; Abdul-Kadir R; Edlund M; Federici AB; Halimeh S; Kamphuisen PW; Konkle BA; Martínez-Perez O; McLintock C; Peyvandi F; Winikoff R
    Am J Obstet Gynecol; 2009 Jul; 201(1):12.e1-8. PubMed ID: 19481722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Menorrhagia, hypermenorrhea and disorders of hemostasis].
    Righini M; Gerber S; Hohlfeld P; de Moerloose P
    J Gynecol Obstet Biol Reprod (Paris); 1999 Sep; 28(5):413-8. PubMed ID: 10566159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of menorrhagia and bleeding disorders in university students.
    Gursel T; Biri A; Kaya Z; Sivaslıoglu S; Albayrak M
    Pediatr Hematol Oncol; 2014 Aug; 31(5):467-74. PubMed ID: 24684279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of abnormal bleeding in women.
    Kouides PA
    Curr Hematol Rep; 2002 Sep; 1(1):11-8. PubMed ID: 12901120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the value of menorrhagia as a predictor for coagulation disorders.
    Edlund M; Blombäck M; von Schoultz B; Andersson O
    Am J Hematol; 1996 Dec; 53(4):234-8. PubMed ID: 8948660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Menorrhagia and inherited disorders of coagulation].
    Franchini M; Capra F; Lippi G; Aprili G; Gandini G
    Minerva Ginecol; 2002 Dec; 54(6):453-60. PubMed ID: 12432326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements for research investigations to clarify the relationships and management of menstrual abnormalities in women with hemostatic disorders.
    Fraser IS; Bonnar J; Peyvandi F
    Fertil Steril; 2005 Nov; 84(5):1360-5. PubMed ID: 16275230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Von Willebrand disease and menorrhagia].
    Touré FA; Kane GM; Diop S; Ndiaye DT; Diao H; Diouf L; Diaw G; Thiam D; Moreau JC; Diakhaté L
    Dakar Med; 2007; 52(2):100-5. PubMed ID: 19102102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding disorders in teenagers presenting with menorrhagia.
    Jayasinghe Y; Moore P; Donath S; Campbell J; Monagle P; Grover S
    Aust N Z J Obstet Gynaecol; 2005 Oct; 45(5):439-43. PubMed ID: 16171484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic management of menometrorrhagia in hemostasis disorders].
    Plu-Bureau G; Horellou MH
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S365-7. PubMed ID: 19268215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric management of adolescents with bleeding disorders.
    James AH
    J Pediatr Adolesc Gynecol; 2010 Dec; 23(6 Suppl):S31-7. PubMed ID: 20934895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Sectional Study of Women and Girls with Congenital Bleeding Disorders: The American Thrombosis and Hemostasis Network Cohort.
    Haley KM; Sidonio RF; Abraham S; Cheng D; Recht M; Kulkarni R
    J Womens Health (Larchmt); 2020 May; 29(5):670-676. PubMed ID: 31905045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.